For the year ending 2025-12-31, BEAM has $1,481,177K in assets. $242,819K in debts. $294,944K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 294,944 | |||
| Marketable securities | 950,266 | |||
| Prepaid expenses and other current assets | 23,478 | |||
| Total current assets | 1,268,688 | |||
| Total property and equipment | 198,627 | |||
| Less accumulated depreciation | 94,127 | |||
| Property and equipment, net | 104,500 | |||
| Restricted cash | 6,676 | |||
| Operating lease right-of-use assets | 100,679 | |||
| Other assets | 634 | |||
| Total assets | 1,481,177 | |||
| Accounts payable | 10,231 | |||
| Accrued expenses and other current liabilities | 55,267 | |||
| Current portion of derivative liabilities | 7,700 | |||
| Current portion of deferred revenue | 6,659 | |||
| Current portion of lease liability | 14,364 | |||
| Current portion of contingent consideration liabilities | 2,714 | |||
| Total current liabilities | 96,935 | |||
| Long-term lease liability | 139,759 | |||
| Long-term portion of contingent consideration liabilities | 5,952 | |||
| Long-term portion of deferred revenue | 0 | |||
| Long-term portion of derivative liabilities | 0 | |||
| Other liabilities | 173 | |||
| Total liabilities | 242,819 | |||
| Common stock, 0.01 par value 250,000,000 shares authorized, 101,748,962 and 83,633,069 issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 1,017 | |||
| Additional paid-in capital | 2,877,449 | |||
| Accumulated other comprehensive (loss) income | 1,111 | |||
| Accumulated deficit | -1,641,219 | |||
| Total stockholders' equity | 1,238,358 | |||
| Total liabilities and stockholders' equity | 1,481,177 | |||
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)